CSBR
Champions Oncology Inc
5.00$
+4.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.3% | 75.1% | 73.3% | 62.6% | 70.3% | 65.0% | 45.8% | 55.6% | 56.7% | 52.2% | 69.2% | 71.2% | |
| 77.7% | 44.7% | 41.1% | 10.6% | 28.7% | 40.2% | 17.0% | 25.5% | 29.5% | 10.0% | 30.3% | 18.1% | |
| 77.7% | 44.7% | 41.1% | 10.6% | 28.7% | 40.2% | 17.0% | 25.5% | 29.5% | 10.0% | 30.3% | 18.1% | |
| 8.8% | 22.7% | 28.4% | 48.5% | 38.9% | 23.0% | 25.3% | 26.9% | 23.3% | 36.5% | 34.7% | 48.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | – | |
| 3.8% | 10.7% | 15.2% | 25.8% | 22.6% | 32.7% | 53.0% | 43.4% | 42.3% | – | – | – | |
| 5.6% | 11.6% | 8.4% | 8.3% | 5.9% | 1.6% | 1.2% | 0.9% | 1.0% | 1.3% | 1.0% | 1.2% | |
| 5.6% | 11.6% | 8.4% | 8.3% | – | – | – | – | – | – | – | – | |
| 33.1% | 95.9% | 95.0% | 100.3% | 80.1% | 75.4% | 73.1% | 74.3% | 86.5% | 107.3% | 88.3% | 84.9% | |
| 31.5% | 91.8% | 93.0% | 92.6% | 71.2% | 59.3% | 40.6% | 49.4% | 63.3% | 82.4% | 73.7% | 73.8% | |
| – | 0.4% | 0.3% | 0.4% | 0.1% | 3.0% | 3.0% | 3.0% | 3.5% | 5.1% | 4.5% | 5.6% | |
| 11.7% | 32.8% | 23.1% | 26.7% | 24.9% | 15.1% | 6.9% | 8.1% | 15.5% | 22.2% | 13.1% | 25.6% | |
| 0.8% | 1.0% | 0.5% | 0.2% | – | – | – | – | – | – | – | – | |
| 66.9% | 4.1% | 5.0% | -0.3% | 19.9% | 24.6% | 26.9% | 25.7% | 13.5% | -7.3% | 11.7% | 14.6% | |
| -431.8% | -1,081.3% | -865.7% | -876.8% | -627.6% | -351.3% | -262.9% | -203.5% | -225.3% | -323.7% | -247.0% | -300.4% | |
| 72.2% | 150.7% | 137.1% | 136.2% | 125.1% | 57.1% | 52.8% | 40.0% | 39.5% | 51.8% | 44.1% | 51.3% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.